Your browser doesn't support javascript.
loading
A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Tedeschi, Alessandra; Greil, Richard; Demirkan, Fatih; Robak, Tadeusz; Moreno, Carol; Barr, Paul M; Anz, Bertrand; Simpson, David; Gaidano, Gianluca; Bairey, Osnat; Stevens, Don; Gill, Devinder; Flinn, Ian W; Kipps, Thomas J; Burger, Jan A; Lin, Jennifer; Webb, Thomas; Fedorov, Viktor; Styles, Lori; Gribben, John G.
Afiliación
  • Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy alessandra.tedeschi@ospedaleniguarda.it.
  • Greil R; Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria.
  • Demirkan F; Dokuz Eylul University, Izmir, Turkey.
  • Robak T; Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.
  • Moreno C; Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
  • Barr PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Anz B; Tennessee Oncology, Chattanooga, TN, USA.
  • Simpson D; North Shore Hospital, Auckland, New Zealand.
  • Gaidano G; Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Bairey O; Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Stevens D; Norton Cancer Institute, Louisville, KY, USA.
  • Gill D; Princess Alexandra Hospital, Brisbane, Australia.
  • Flinn IW; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
  • Kipps TJ; University of California, San Diego, Moores Cancer Center, La Jolla, CA, USA.
  • Burger JA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lin J; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Webb T; Janssen Ltd, High Wycombe, UK.
  • Fedorov V; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Styles L; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Gribben JG; Barts Cancer Institute, Queen Mary University of London, London, UK.
Haematologica ; 105(4): e164-e168, 2020 04.
Article en En | MEDLINE | ID: mdl-31413095
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Clorambucilo / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Clorambucilo / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article